Preclinical Targeting of Leukemia-Initiating Cells in the Development Future Biologics for Acute Myeloid Leukemia

The authors summarize preclinical advances in targeting acute myeloid leukemia leukemia-initiating cells, including strategies to exploit metabolic vulnerabilities, such as the reliance on oxidative phosphorylation.